<DOC>
	<DOC>NCT00925678</DOC>
	<brief_summary>Investigate safety/tolerability after a single dose intranasal administration of DSP-3025 comparator placebo to healthy male volunteers and seasonal allergic rhinitis male patients out of season.</brief_summary>
	<brief_title>DSP-3025 Study of Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<criteria>Body mass index (BMI) between 18.5 and 25 kg/ m2 and a weight between 50 and 80 kg No clinically relevant abnormal findings History of cedar and/or Japanese cypress pollen induced seasonal allergic rhinitis for at least the previous 2 years (only Allergic rhinitis) Acute illness which requires medical intervention Definite or suspected personal history of adverse drug reactions or drug hypersensitivity Clinical relevant disease or disorder (past or present) A history of asthma</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>